While IL-12 and IL-18 have demonstrated potential in promoting CAR T cell proliferation and persistence without preconditioning in murine models (201, 202), their pro-inflammatory nature poses a significant challenge for their application in autoimmune diseases. This evidence concerns the gene IL18 and autoimmune disease.